Navigation Links
Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
Date:5/14/2013

BLUE BELL, Pa., May 14, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that in a preclinical study of Inovio's SynCon® DNA vaccine against Ebola and Marburg filoviruses, labeled "Category A" bioterrorism agents by the U.S. government, the vaccine induced strong and broad immune responses and demonstrated 100% protection against death following a challenge with multiple variants of the pathogen in two animal models.

There is no approved vaccine or therapy available against these highly virulent pathogens that have killed up to 90% of the people they infected. Because these viruses could potentially be easily transmitted, result in high mortality rates and cause a major public health impact, various agencies are seeking solutions for public health preparedness. A DNA vaccine could offer faster design and manufacturing timelines than traditional vaccine approaches, but particularly important, Inovio's SynCon® products offer the potentially preemptive advantage of enabling a design to provide broad protection encompassing multiple families of these so-called filoviruses.

Preclinical data was published in the peer-reviewed journal Molecular Therapy in a paper, "Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola," authored by Inovio researchers and collaborators.

Using Inovio's proprietary SynCon® design approach, Inovio researchers developed a polyvalent DNA vaccine consisting of three consensus plasmids to broadly target variant virus strains within three distinct families of Ebola and Marburg viruses. In the first part of this study, following two vaccinations using Inovio's proprietary CELLECTRA® electroporation device, 100% of vaccinated guinea pigs were protected from death following a virus challenge. The researchers observed significant increases in neutr
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  Zacks.com announces the ... day the Zacks Equity Research analysts discuss the latest ... Stocks recently featured in the blog include the Avanir Pharmaceuticals ... (Nasdaq: NPSP - Free Report ), Orexigen (Nasdaq: ... MDVN - Free Report ) and Gilead (Nasdaq: ...
(Date:9/18/2014)... Australia , Sept. 18, 2014 Veterinary ... of Dr. Ashraf Hanna , M.D., Ph.D., and ... Board of Directors. Dr. Hanna is the Vice President ... Chief Financial Officer for the Genentech Foundation, while Dr. ... Head of Business Development and Licensing for Roche Pharma. ...
(Date:9/18/2014)... , Sept. 18, 2014   Regulus Therapeutics ... biopharmaceutical company leading the discovery and development of ... initiated its ATHENA natural history of disease study ... kidney disease with no approved therapy. The ATHENA ... of renal function markers such as Glomerular Filtration ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6
... , BOCA RATON, Fla., Nov. 16 CPG has ... Management (PLM) Release 9.3 at Avema Pharma Solutions, a division ... operation of pharmaceutical, over-the-counter (OTC), and nutritional solid-dose products based ... live at Avema on September 28, 2009. "As a contract ...
... , JAMAICA PLAIN, Mass., Nov. 16 ... presentation today at the AACR-NCI-EORTC International Conference Molecular Targets ... efficiently penetrates the blood brain barrier and may be ... Olaf van Tellingen, Ph.D. of The Netherlands Cancer Institute, ...
Cached Medicine Technology:CPG Implements First-Ever Agile PLM Release 9.3 at Avema Pharma Solutions 2Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics 2Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics 3
(Date:9/18/2014)... It is almost time to park your Hyundai to ... happier kids. The South Florida Hyundai Dealers Association is ... Children’s Hospital 5K Run/Walk. Its title sponsor is Hyundai ... 5K will take place on Saturday August 20th. The ... City Hall located at 405 Biltmore Way. Registration is ...
(Date:9/18/2014)... Africa (PRWEB) September 18, 2014 Phela ... adopt the HABIT™ Program in South Africa. ... Health and Wellness, and distributed in South Africa by ... the HABIT program, which has been tailored to address ... HABIT™ focuses on behavior modification and chronic disease prevention. ...
(Date:9/18/2014)... in German . ... have won the ,International Space Station Research Competition, with ... prize, the scientists will see the International Space Station ... involves crystallizing two proteins of the hepatitis C virus ... the International Space Station is scheduled to lift off ...
(Date:9/18/2014)... PlatinumCode, a leading manufacturer and ... for the healthcare industry, announced earlier this month ... of their profits of the sale of eligible ... the announcement, PlatinumCode has launched various marketing efforts ... and hospital labs with their popular “Pink Packs” ...
(Date:9/18/2014)... T-System Inc. today announced Holyoke ... system — EV™ for physicians — ... several best-of-breed solutions, Holyoke chose T-System’s solution because ... productivity and reimbursement, but also its ability to ... be used to capture emergency department, (ED) nurse ...
Breaking Medicine News(10 mins):Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 3Health News:Hepatitis C virus proteins in space 2Health News:PlatinumCode Commits to Donating Five Percent of Profits from the sale of Pink Products to Support Breast Cancer Awareness 2Health News:Holyoke Medical Center ER Improves Productivity and Reimbursement with T-System 2
... , WASHINGTON , Jan. 14 Thirteen ... Department of Health and Human Services, Office of the Inspector General ... scheme to defraud the Medicare program of more than $14.5 ... of the Criminal Division; U.S. Attorney Barbara L. McQuade ...
... , NEWTON, Mass. , ... Centers for Medicare and Medicaid Services (CMS) will make ... acute-care settings to inpatient rehabilitation facilities (IRFs), according to ... building secure electronic patient-transition networks for hospitals, post-acute providers ...
... , National Sleep Foundation Launches Air Purification Product ... Jan. 14 The National Sleep Foundation (NSF) is ... leading indoor air cleaner manufacturer, to launch a new National ... environment.  The National Sleep Foundation Bedroom Machine by Austin Air ...
... advise people with medical conditions that could affect their ... wheel, according to research from the University of Warwick., ... many healthcare professionals are failing to tell patients with ... they are not fit to drive. In a ...
... doubled in young children, study finds , THURSDAY, Jan. ... vaccine for bacterial pneumonia was introduced in the United ... pneumonia because of pneumococcus has decreased by 50 percent ... , But the scientists also found a 70 percent ...
... ... of its new retail site, CoastToCoastMattress.com. CoastToCoastMattress.com is an e-commerce website dedicated to making ... United States. , ... (PRWEB) January 14, 2010 -- Coast To Coast Mattress is pleased to announce the ...
Cached Medicine News:Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 2Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 3Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 4Health News:2010: A Tough Year Ahead for Discharge Planners, but Help Is Available 2Health News:2010: A Tough Year Ahead for Discharge Planners, but Help Is Available 3Health News:National Sleep Foundation Partners With Austin Air Systems 2Health News:National Sleep Foundation Partners With Austin Air Systems 3Health News:National Sleep Foundation Partners With Austin Air Systems 4Health News:Health care professionals failing to tell patients they are not fit to drive 2Health News:Lung Infection Up in Wake of Kids' Pneumonia Vaccine 2Health News:Coast To Coast Mattress Announces the Grand Opening of CoastToCoastMattress.com 2
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
Delicate strong curved serrated tips. Serrated handle with dull finish....
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Two 2.75 mm long tips separated 1 mm with 1 x 2 teeth. Serrated handle with dull finish....
Medicine Products: